This document defines and provides testing methods and normal values for various tests used to evaluate bleeding disorders and platelet function. Some of the key tests described are bleeding time, which measures platelet function and clot formation; prothrombin time and activated partial thromboplastin time, which evaluate the intrinsic and extrinsic coagulation pathways; and thrombin time, which assesses the final stage of coagulation. Normal ranges are provided to interpret test results.
This document defines and provides testing methods and normal values for various tests used to evaluate bleeding disorders and platelet function. Some of the key tests described are bleeding time, which measures platelet function and clot formation; prothrombin time and activated partial thromboplastin time, which evaluate the intrinsic and extrinsic coagulation pathways; and thrombin time, which assesses the final stage of coagulation. Normal ranges are provided to interpret test results.
Original Description:
Here is an easy tabulation showing different investigations for bleeding disorders
This document defines and provides testing methods and normal values for various tests used to evaluate bleeding disorders and platelet function. Some of the key tests described are bleeding time, which measures platelet function and clot formation; prothrombin time and activated partial thromboplastin time, which evaluate the intrinsic and extrinsic coagulation pathways; and thrombin time, which assesses the final stage of coagulation. Normal ranges are provided to interpret test results.
This document defines and provides testing methods and normal values for various tests used to evaluate bleeding disorders and platelet function. Some of the key tests described are bleeding time, which measures platelet function and clot formation; prothrombin time and activated partial thromboplastin time, which evaluate the intrinsic and extrinsic coagulation pathways; and thrombin time, which assesses the final stage of coagulation. Normal ranges are provided to interpret test results.
Download as DOCX, PDF, TXT or read online from Scribd
Download as docx, pdf, or txt
You are on page 1of 2
Bleeding Disorders
Definition Methods Normal Value
Bleeding Time Bleeding time is a Duke’s method, Duke method: laboratory test to assess Ivy’s method and 1-5 min platelet function and the template method Ivy method: 5- body’s ability to form a clot 11 min Template method: 2-9 min Capillary Fragility Test This test measures the Hess 0-5 petechiae ability of the capillaries to Test/Tourniquet withstand increased stress test Platelet aggregation test This test measures the - - ability of platelets to aggregate in response to agonist like thrombin Platelet adhesiveness test This test measures the - The normal ability of platelets to range is 75% to adhere to glass surface 95% of platelet retention Clotting Time It measures the time taken Lee-white method 4-11 min for the fresh blood to clot Prothrombin time Prothrombin time (PT) is Quick’s one stage 11-16 seconds the time taken for citrated prothrombin time plasma to clot after the addition of tissue thromboplastin and calcium Prothrombin This test is performed to - - Consumption test determine the quantity of prothrombin remaining in the serum after clot is formed Partial thromboplastin It is a measure of intrinsic - 60-80 seconds time and common coagulation pathways Activated Partial APTT is the time taken for - 30-40 seconds thromboplastin time citrated plasma to clot in the presence of a surface activator (Kaolin), phospholipid and calcium Thrombin Time Thrombin time detects the - 15 to 20 seconds effectiveness of the final stage of coagulation in which fibrinogen is converted to fibrin Plasma recalcification A measure of the time - Platelet rich time taken for clot formation in plasma:100 to recalcified blood 150 seconds Platelet poor plasma:135 to 240 seconds Clot retraction time It assess the clot stability - Normal clot and platelet functions retraction shows more than 50% of serum at end of 24 hrs